Specialty Drugs

Pew’s specialty drugs research initiative identifies policy options that will help manage such costs and provide patients with the lifesaving treatments they need.

Research & Analysis

View All
  • Compounding Is Not a Safe Solution to Rising Drug Prices

    Pharmacists often make drugs for patients whose clinical needs cannot be met by a commercially available product, a practice known as compounding. But should pharmacists compound drugs to reduce costs for patients and the health care system? Read More

  • Beyond EpiPen: Prices of Lifesaving Epinephrine Products Soar

    People with life-threatening allergies have long relied on the EpiPen, an injection device that dispenses epinephrine, to reverse symptoms of severe allergic reactions. But steep price increases for the drug over the past decade—including a more than 100 percent increase in the past three years—have sparked outrage from consumers who now face sizable, and often unaffordable,... Read More

  • What’s Driving Increased Pharmaceutical Spending?

    In April, IMS Health, a pharmaceutical data analytics company, reported that drug spending in the U.S. totaled $310 billion in 2015, an 8.4 percent increase from the previous year. Unlike some other estimates of drug costs, this analysis takes into account the rebates and other discounts that drug companies grant payers to effectively lower the price of drugs compared with their invoiced prices. ... Read More

Media Contact

Erin Davis

Officer, Communications

202.540.6677